Abbott Drops Patent Claims Over Teva's Generic Simcor
Law360, New York (January 4, 2012, 4:48 PM EST) -- Abbott Laboratories on Tuesday dropped five consolidated patent infringement suits against Teva Pharmaceuticals Industries Ltd. over Teva's attempts to market a generic version of Abbott's cholesterol drug Simcor.
According to a joint stipulation of dismissal filed in a Delaware federal court last week, the parties agreed to pay their own costs and neither admitted to liability in the two-year-old dispute. U.S. District Judge Sue Robinson signed an order dismissing the cases with prejudice Tuesday.
Abbott and Abbott Respiratory LLC lodged the most recent complaint in August over Teva's bid for U.S. Food and Drug Administration approval to market a generic Simcor,...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!